Allergan blueprints a big Texas expansion amid battle with spendthrift Valeant

Allergan ($AGN) has signed a lease for big chunk of office space in Texas, according to the Austin Business Journal, keeping quiet on its plans as it slashes jobs around the globe. The California drugmaker is leasing a 90,000-square-foot space in Austin, the Journal reports, and Allergan isn't commenting on just what for. Meanwhile, the company is still in the midst of a public and protracted fight with Valeant Pharmaceuticals ($VRX), which has made a series of hostile takeover bids. In an effort to cut costs--and perhaps assuage shareholders who may be swayed by Valeant's promise of a leaner operation--Allergan is also cutting about 13% of its workforce, amounting to about 1,500 jobs. News

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

City of Hope and Canadian biotech Biovaxys Technology reported positive animal data for their COVID vaccines that could offer alternatives to mRNA.

4D is adding a trio of executives to spearhead its work in heart, eye and lung diseases as it pushes programs into and through the clinic.

Janssen has sent off its mutation-specific non-small cell lung cancer drug amivantamab to the FDA.